Small Molecule Penalty

Incubate launches "Small Molecules, Big Voices" series to highlight the value of small molecule drugs

Today, Incubate launched the "Small Molecules, Big Voices" video series to illustrate the importance of small molecule drugs to patients,...

Incubate Launches Life Science Investment Tracker to Analyze Impact of the Inflation Reduction Act

WASHINGTON (June 13) -- Today, Incubate launched the Life Science Investment Tracker, a database monitoring changes in investment,...

From Idea To Prescription: Bringing A Drug To Market

Bringing a new drug to market is a complex and lengthy process that involves multiple phases of research, development, testing, and...

Incubate Participates In Pulse Webinar

Discussion on the vital role of M&A in bringing the next generation of biopharmaceutical breakthroughs to patients. Featured guests...

Mary R. Grealy On The Small Molecule Penalty, U.S. Dominance In Life Sciences, And More

Incubate Executive Director John Stanford sat down this week with Mary R. Grealy, CEO of the Healthcare Leadership Council, to discuss...

The Small Molecule Penalty: Explained By Incubate

The Inflation Reduction Act- Explained By Incubate

Incubate breaks down the Inflation Reduction Act, diving into implications and potential impacts on life science development. Keep up...

The Pathway To Drug Development Driven By Private Capital

Video narrated by Sara Nayeem, Avoro Ventures